Twynsta and Thrombocytopenia - a phase IV clinical study of FDA data

Summary:

Thrombocytopenia is reported as a side effect among people who take Twynsta (amlodipine besylate; telmisartan), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Amlodipine, and have Carcinoid tumor.

The phase IV clinical study analyzes which people have Thrombocytopenia when taking Twynsta. It is created by eHealthMe based on reports of 1,017 people who have side effects when taking Twynsta from the FDA, and is updated regularly.

What is Twynsta?

Twynsta has active ingredients of amlodipine besylate; telmisartan. It is often used in high blood pressure. eHealthMe is studying from 1,063 Twynsta users. Check the latest studies of Twynsta.

What is Thrombocytopenia?

Thrombocytopenia (decrease of platelets in blood) is found to be associated with 2,792 drugs and 4,869 conditions by eHealthMe. Check the latest studies of Thrombocytopenia.

On Jul, 15, 2026

1,017 people reported to have side effects when taking Twynsta.
Among them, 12 people (1.18%) have Thrombocytopenia.

Among these 12 people:

How long have people been on Twynsta when they have Thrombocytopenia? *

What is the gender of people who have Thrombocytopenia when taking Twynsta? *

female: 27.27 %
male: 72.73 %

What is the age of people who have Thrombocytopenia when taking Twynsta? *

What are other drugs people take besides Twynsta? *

What are other side effects people have besides Thrombocytopenia? *

Fatigue (feeling of tiredness): 4 people, 33.33%
Urinary Tract Infection: 3 people, 25.00%
Prostatomegaly (enlargement of the prostate): 3 people, 25.00%
Gallstones (stone formation by bile component): 3 people, 25.00%
Kidney Stones: 3 people, 25.00%
Nephrogenic Anaemia (anaemia due to kidney disease): 3 people, 25.00%
Diabetes: 3 people, 25.00%
Rashes (redness): 2 people, 16.67%
Death: 2 people, 16.67%
Eosinophilia (eosinophil count in the peripheral blood exceeds): 2 people, 16.67%

What are the existing conditions these people have? *

Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 2 people, 16.67%
Carcinoid Tumor: 2 people, 16.67%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 8.33%
Paroxysmal Nocturnal Haemoglobinuria (haemoglobin in the urine): 1 person, 8.33%
Neuroendocrine Tumor: 1 person, 8.33%
Multiple Myeloma (cancer of the plasma cells): 1 person, 8.33%
High Blood Cholesterol: 1 person, 8.33%
Diabetes: 1 person, 8.33%
Cardiac Failure Congestive: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Twynsta and have Thrombocytopenia?

- Check whether Thrombocytopenia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Twynsta:

Twynsta (1,063 reports)

Thrombocytopenia treatments and more:

Thrombocytopenia (285,083 reports)

How severe was Thrombocytopenia and when was it recovered:

Thrombocytopenia in Twynsta

Expand to all the drugs that have ingredients of amlodipine besylate; telmisartan:

Thrombocytopenia and drugs with ingredients of amlodipine besylate; telmisartan (50 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Twynsta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Thrombocytopenia:

Thrombocytopenia (2,792 drugs)

Browse all the conditions that are associated with Thrombocytopenia:

Thrombocytopenia (4,869 conditions)

Related publications that referenced our studies

YavasogluI, I., TurgutkayaII, A., & BolamanIII, Z., "Chlorella-induced thrombocytopenia", DATA, 2018 Jan .
Rasmy A, Rahal M, Kisana M, Ahmad S, Salah A, "Morphine induced thrombocytopenia: A case report", Journal of Case Reports and Images in Oncology, 2015 Dec .
Onder H, Arsava EM, Arat A, Topcuoglu MA, "Acute middle cerebral artery occlusion treated by thrombectomy in a patient with myelodysplastic syndrome and severe thrombocytopenia", Journal of vascular and interventional neurology, 2015 Jan .
YavasogluI, I., TurgutkayaII, A., & BolamanIII, Z., "Chlorella-induced thrombocytopenia", DATA, 2018 Jan .
Rasmy A, Rahal M, Kisana M, Ahmad S, Salah A, "Morphine induced thrombocytopenia: A case report", Journal of Case Reports and Images in Oncology, 2015 Dec .
Onder H, Arsava EM, Arat A, Topcuoglu MA, "Acute middle cerebral artery occlusion treated by thrombectomy in a patient with myelodysplastic syndrome and severe thrombocytopenia", Journal of vascular and interventional neurology, 2015 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on amlodipine besylate; telmisartan (the active ingredients of Twynsta) and Twynsta (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.